These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6586289)

  • 1. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
    Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
    Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL; Blair OC; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis for differential cellular sensitivity to 8-azaguanine and 6-thioguanine.
    van Diggelen OP; Donahue TF; Shin SI
    J Cell Physiol; 1979 Jan; 98(1):59-71. PubMed ID: 762202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered 5-phosphoribosyl 1-pyrophosphate amidotransferase activity in 6-thioguanine-resistant HL-60 human acute promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3679-85. PubMed ID: 6589043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of differentiation-inducer-resistant HL-60 cells.
    Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
    Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of spontaneous hypoxanthine phosphoribosyltransferase mutations in thioguanine-resistant HL-60 human leukemia cells.
    Monnat RJ
    Cancer Res; 1989 Jan; 49(1):81-7. PubMed ID: 2908855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double minute chromatin bodies and other chromosome alterations in human myeloid HL-60 leukemia cells susceptible or resistant to induction of differentiation by phorbol-12-myristate-13-acetate.
    Au WW; Callaham MF; Workman ML; Huberman E
    Cancer Res; 1983 Dec; 43(12 Pt 1):5873-8. PubMed ID: 6580064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
    Zimm S; Johnson GE; Poplack DG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
    Ishiguro K; Schwartz EL; Sartorelli AC
    J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
    Cheng HW; Armstrong RD; Sadée W
    Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to O6-methylguanine and 6-thioguanine cytotoxic effects: a cross-resistant phenotype in N-methylnitrosourea-resistant Chinese hamster ovary cells.
    Aquilina G; Giammarioli AM; Zijno A; Di Muccio A; Dogliotti E; Bignami M
    Cancer Res; 1990 Jul; 50(14):4248-53. PubMed ID: 2364383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased PRPP synthetase activity in cultured rat hepatoma cells containing mutations in the hypoxanthine-guanine phosphoribosyltransferase gene.
    Graf LH; McRoberts JA; Harrison TM; Martin DW
    J Cell Physiol; 1976 Jul; 88(3):331-42. PubMed ID: 178676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for thioguanine-resistant human leukemia.
    Howell SB; Murphy MP; Johnson J; Wamsley P; Verma I
    Mol Biol Med; 1987 Jun; 4(3):157-68. PubMed ID: 3476817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal organization of amplified genes in multidrug-resistant Chinese hamster cells.
    Biedler JL; Chang TD; Scotto KW; Melera PW; Spengler BA
    Cancer Res; 1988 Jun; 48(11):3179-87. PubMed ID: 3365701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic alterations associated with the acquisition of doxorubicin resistance: possible significance of chromosome 7 alterations.
    Slovak ML; Hoeltge GA; Trent JM
    Cancer Res; 1987 Dec; 47(24 Pt 1):6646-52. PubMed ID: 3677098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for the formation of double minutes from prematurely condensed chromosomes of replicating micronuclei in drug-treated Chinese hamster ovary cells undergoing DNA amplification.
    Sen S; Hittelman WN; Teeter LD; Kuo MT
    Cancer Res; 1989 Dec; 49(23):6731-7. PubMed ID: 2819718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amplification of portions of the genome in mammalian somatic cells resistant to colchicine. I. Chromosome 4 trisomy in the development of gene amplification and colchicine resistance in Djungarian hamster cells].
    Kopnin BP
    Genetika; 1982 Sep; 18(9):1503-12. PubMed ID: 6890494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cloning assay for 6-thioguanine resistance provides evidence against certain somatic mutational theories of aging.
    Horn PL; Turker MS; Ogburn CE; Disteche CM; Martin GM
    J Cell Physiol; 1984 Nov; 121(2):309-15. PubMed ID: 6490730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line.
    Yamashina K; Miller BE; Heppner GH
    Cancer Res; 1986 May; 46(5):2396-401. PubMed ID: 3084067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level, unstable adriamycin resistance in a Chinese hamster mutant cell line with double minute chromosomes.
    Howell N; Belli TA; Zaczkiewicz LT; Belli JA
    Cancer Res; 1984 Sep; 44(9):4023-9. PubMed ID: 6744317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.